Alentis Therapeutics Appoints Luca Santarelli as Chairperson

Alentis Therapeutics announced the appointment of Dr. Luca Santarelli as the Chair of its Board of Directors.

Dr. Luca has been a member of Alentis’ board since 2021 and brings over 20 years of experience in academic and pharmaceutical R&D. He recently served as the founder and CEO of VectivBio AG and previously held the position of CEO and co-founder of Therachon AG, which was acquired by Pfizer.

Alentis Therapeutics is a biotechnology company specializing in the development of therapeutics for fibrotic diseases and cancer.